Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02886676Phase 4Completed
Phase 4, randomised, double-blind trial (2 arms), sponsored by Tatyasaheb Kore Dental College & Research Centre. Primary endpoints: Superoxide Dismutase at 3 months and Malondialdehyde at 3 months. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02886676.